These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38197670)

  • 1. Impact of the COVID-19 pandemic on the in-hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population-based study.
    Wolfkamp W; Meijer J; van Hoeve JC; van Erning F; de Geus-Oei LF; de Hingh I; Veltman J; Siesling S;
    Cancer Med; 2024 Jan; 13(1):e6861. PubMed ID: 38197670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P
    Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020.
    Meijer J; Elferink MAG; Vink GR; Sijtsma FPC; Buijsen J; Nagtegaal ID; Tanis PJ; Wumkes ML; de Hingh IHJT; Siesling S;
    Int J Colorectal Dis; 2022 Sep; 37(9):2013-2020. PubMed ID: 35986108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands.
    Toes-Zoutendijk E; Vink G; Nagtegaal ID; Spaander MCW; Dekker E; van Leerdam ME; Siesling S; Lansdorp-Vogelaar I; Elferink MAG;
    Eur J Cancer; 2022 Jan; 161():38-43. PubMed ID: 34915408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The real-word impact of breast and colorectal cancer surgery during the SARS-CoV-2 pandemic.
    Losurdo P; Samardzic N; Di Lenarda F; de Manzini N; Giudici F; Bortul M
    Updates Surg; 2022 Jun; 74(3):1063-1072. PubMed ID: 34978052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
    Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
    Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
    J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How COVID-19 Impacted Colonoscopy Utilization and Colorectal Cancer Detection in Hawai'i in 2020.
    Jain A; Jain S; Pagano I
    Hawaii J Health Soc Welf; 2024 Jul; 83(7):200-203. PubMed ID: 38974803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
    Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
    JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
    Morris EJA; Goldacre R; Spata E; Mafham M; Finan PJ; Shelton J; Richards M; Spencer K; Emberson J; Hollings S; Curnow P; Gair D; Sebag-Montefiore D; Cunningham C; Rutter MD; Nicholson BD; Rashbass J; Landray M; Collins R; Casadei B; Baigent C
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):199-208. PubMed ID: 33453763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Covid-19 on Breast Cancer Screening.
    Stevanato KP; Pelloso FC; Borghesan DHP; Ribeiro HF; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2024 Aug; 25(8):2703-2710. PubMed ID: 39205568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
    Eijkelboom AH; de Munck L; Vrancken Peeters MTFD; Broeders MJM; Strobbe LJA; Bos MEMM; Schmidt MK; Guerrero Paez C; Smidt ML; Bessems M; Verloop J; Linn S; Lobbes MBI; Honkoop AH; van den Bongard DHJG; Westenend PJ; Wesseling J; Menke-van der Houven van Oordt CW; Tjan-Heijnen VCG; Siesling S;
    J Hematol Oncol; 2021 Apr; 14(1):64. PubMed ID: 33865430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
    Malmgren JA; Guo B; Atwood MK; Hallam P; Roberts LA; Kaplan HG
    Breast Cancer Res Treat; 2023 Nov; 202(1):105-115. PubMed ID: 37584882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
    Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
    Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.